Charlottesville, VA –May 18, 2017—BrightSpec announced today the exclusive technology license for a new technique for chiral analysis from the University of Virginia Licensing and Ventures Group.
The licensed technology, entitled “Multiplexed Cavity-Enhanced Fourier Transform Microwave Spectrometer for Chiral Analysis” enables fast, precise measurement of enantiomer ratios in complex chemical mixtures, without the need for chromatography. The most recent licensed IP complements the existing BrightSpec technique for sensitive chiral analysis by three-wave mixing, under exclusive license from Harvard University. The recent breakthroughs in the chiral tagging technique arise from research at the University of Virginia lab of Brooks Pate, inventor of the chirped-pulse Fourier-transform technique in rotational spectroscopy. The impact for medicinal chemists it a newfound ability to quickly and precisely differentiate enantiomeric excess (ee) ratios, a critical analysis for drug discovery, development and manufacturing of new, safe, and highly effective pharmaceuticals. The new technique is available as an add-on feature to certain BrightSpec instruments.
BrightSpec delivers stand-alone products for mixture analysis in R&D, pharmaceutical drug development and process control, fine chemicals, food, and advanced manufacturing sectors. BrightSpec received research funding from the US ARMY, the National Science Foundation, and the Virginia BioHealth Research Corporation. For more information, please contact Justin Neill (CTO) or Bob Lloyd (CEO) at 434-202-2391, or visit www.brightspec.com.